Emerging gliptins for type 2 diabetes

By Cahn Avivit  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 245-258

Informa Healthcare

Access to resources Recommend Favorite

Gliptins – do they increase cardiovascular risk or benefit?

By Doggrell Sheila A   Dimmitt Simon B  

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 675-680

Informa Healthcare

Access to resources Recommend Favorite

Cholinesterase inhibitors: a patent review (2007 – 2011)

By de los Ríos Cristóbal  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 8, 2012-08 ,pp. : 853-869

Informa Healthcare

Access to resources Recommend Favorite

Androgen receptor antagonists: a patent review (2008 – 2011)

By Mohler Michael L   Coss Christopher C   Duke Charles B   Patil Shivaputra A   Miller Duane D   Dalton James T  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 541-565

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies for glaucoma: a patent review 2007 – 2011

By Carta Fabrizio   Supuran Claudiu T   Scozzafava Andrea  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 1, 2012-01 ,pp. : 79-88

Informa Healthcare

Access to resources Recommend Favorite